loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 203993 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CLOBAZAM (1)

filter

01 LUNDBECK PHARMS LLC (1)

filter

01 SUSPENSION;ORAL (1)

filter

01 2.5MG/ML (1)

filter

01 USA (1)

URL Supplier Web Content
SUSPENSION;ORAL
2.5MG/ML
ONFI
USA
203993
2012-12-14
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 203993

Looking for CTD TGA MCC DOSSIER APPLICATION 203993 1

19

H. Lundbeck AS, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is CLOBAZAM, with a corresponding application number 203993 and regulatory information .

proudly manufactured in the

approval since 2012-12-14

H. Lundbeck AS's ONFI SUSPENSION;ORAL, medication with 2.5MG/ML of CLOBAZAM.

Post Enquiry
POST ENQUIRY